These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3501427)

  • 1. Solution conformation of carboxy-terminal fragments of the third component of human complement C3: proton nuclear magnetic resonance study of C3a, des-Arg-C3a, and C3a Arg69.
    Muto Y; Fukumoto Y; Arata Y
    J Biochem; 1987 Sep; 102(3):635-41. PubMed ID: 3501427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton nuclear magnetic resonance study of the third component of complement: solution conformation of the carboxyl-terminal segment of C3a fragment.
    Muto Y; Fukumoto Y; Arata Y
    Biochemistry; 1985 Nov; 24(23):6659-65. PubMed ID: 3878728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton nuclear magnetic resonance study of the solution conformation of C3a-Arg69, a 69-residue N-terminal fragment of the third component of complement.
    Muto Y; Inagaki F; Arata Y
    J Biochem; 1989 Feb; 105(2):330-7. PubMed ID: 2656667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide.
    Lu ZX; Fok KF; Erickson BW; Hugli TE
    J Biol Chem; 1984 Jun; 259(12):7367-70. PubMed ID: 6610676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H NMR studies of human C3a anaphylatoxin in solution: sequential resonance assignments, secondary structure, and global fold.
    Chazin WJ; Hugli TE; Wright PE
    Biochemistry; 1988 Dec; 27(26):9139-48. PubMed ID: 3266557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helical conformation at the carboxy-terminal portion of human C3a is required for full activity.
    Hoeprich PD; Hugli TE
    Biochemistry; 1986 Apr; 25(8):1945-50. PubMed ID: 3486674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary structure of complement component C3a anaphylatoxin in solution as determined by NMR spectroscopy: differences between crystal and solution conformations.
    Nettesheim DG; Edalji RP; Mollison KW; Greer J; Zuiderweg ER
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5036-40. PubMed ID: 3260670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
    Hugli TE
    J Biol Chem; 1975 Nov; 250(21):8293-301. PubMed ID: 1238393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
    Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
    Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The primary structure of porcine C3a anaphylatoxin.
    Corbin NC; Hugli TE
    J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of in vitro natural killer activity by the third component of complement: role for the C3a fragment.
    Charriaut C; Senik A; Kolb JP; Barel M; Frade R
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6003-7. PubMed ID: 6985269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.
    Morgan EL; Weigle WO; Hugli TE
    J Exp Med; 1982 May; 155(5):1412-26. PubMed ID: 6978374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet activation by C3a and C3a des-arg.
    Polley MJ; Nachman RL
    J Exp Med; 1983 Aug; 158(2):603-15. PubMed ID: 6604123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proton nuclear magnetic resonance study of the conformation of bovine anaphylatoxin C5a in solution.
    Zarbock J; Gennaro R; Romeo D; Clore GM; Gronenborn AM
    FEBS Lett; 1988 Oct; 238(2):289-94. PubMed ID: 3262536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor C3f is a spasmogenic fragment released from C3b by factors I and H: the heptadeca-peptide C3f was synthesized and characterized.
    Ganu VS; Müller-Eberhard HJ; Hugli TE
    Mol Immunol; 1989 Oct; 26(10):939-48. PubMed ID: 2531841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data.
    Zuiderweg ER; Nettesheim DG; Mollison KW; Carter GW
    Biochemistry; 1989 Jan; 28(1):172-85. PubMed ID: 2784981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Hugli TE; Erickson BW
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation, purification and functional characterization of three C3a anaphylatoxins in rainbow trout: role in leukocyte chemotaxis and respiratory burst.
    Rotllant J; Parra D; Peters R; Boshra H; Sunyer JO
    Dev Comp Immunol; 2004 Jun; 28(7-8):815-28. PubMed ID: 15043949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and partial characterization of human and porcine C3a anaphylatoxin.
    Hugli TE; Vallota EH; Müller-Eberhard HJ
    J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.